PRIMARY CHEMOABLATION OF LOW-GRADE INTERMEDIATE-RISK NON-MUSCLE-INVASIVE BLADDER CANCER USING UGN-102, A MITOMYCIN-CONTAINING REVERSE THERMAL GEL (OPTIMA II): A PHASE 2B, OPEN-LABEL, SINGLE-ARM TRIAL Meeting Abstract

cited authors

  • Chevli, Kent; Shore, Neal; Trainer, Andrew; Smith, Angela B.; Saltzstein, Daniel; Ehrlich, Yaron; Raman, Jay D.; Friedman, Boris; D'Anna, Richard; Morris, David; Hu, Brian; Tyson, Mark; Sankin, Alexander; Kates, Max; Linehan, Jennifer; Scherr, Douglas; Kester, Steven; Verni, Michael; Chamie, Karim; Karsh, Lawrence; Cinman, Arnold; Lahiri, Soumi; Meads, Andrew; Malinowski, Madlen; Gabai, Nimrod; Raju, Sunil; Seltzer, Elyse; Schoenberg, Mark; Huang, William C.

authors

Publication Date

  • September 1, 2021

webpage

published in

category

start page

  • E730

end page

  • E731

volume

  • 206